Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.
Affiliation
3rd Floor Mulberry House, Fulham Road, London SW3 6JJ, UK.Issue Date
2012-04
Metadata
Show full item recordAbstract
As a group of European nurses familiar with treating patients with renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC) using targeted/chemo- therapies, we aimed to review strategies for managing adverse events (AEs) associated with one targeted therapy, sorafenib.Citation
Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group. 2012, 16 (2):172-84 Eur J Oncol NursJournal
European Journal of Oncology NursingDOI
10.1016/j.ejon.2011.05.001PubMed ID
21641280Type
ArticleLanguage
enISSN
1532-2122ae974a485f413a2113503eed53cd6c53
10.1016/j.ejon.2011.05.001
Scopus Count
Collections
Related articles
- Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
- Authors: Lee WJ, Lee JL, Chang SE, Lee MW, Kang YK, Choi JH, Moon KC, Koh JK
- Issue date: 2009 Nov
- Managing adverse events associated with sorafenib in renal cell carcinoma.
- Authors: Edmonds K, Spencer-Shaw A
- Issue date: 2010 Jan 14-27
- Sorafenib for the treatment of advanced renal cell carcinoma.
- Authors: Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, Liang C, Booth B, Chidambaram N, Morse D, Sridhara R, Garvey P, Justice R, Pazdur R
- Issue date: 2006 Dec 15
- Sorafenib: a promising new targeted therapy for renal cell carcinoma.
- Authors: Wood LS, Manchen B
- Issue date: 2007 Oct
- Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
- Authors: Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC, Kuo TT, Hsieh JJ, Chang JW
- Issue date: 2008 Mar